Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome

Psychoneuroendocrinology

Volumn 29, Issue 6, 2004, Pages 724-732

  Cleare, A J ^a,c   O'Keane, V ^a,b   Miell, J P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenal gland; Adrenal steroids; Corticotrophin; Cortisol; Hypothalamo pituitary adrenal axis

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; PLACEBO; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW DRUG DOSE; MALE; MENSTRUAL CYCLE; PHYSICAL DISABILITY; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AREA UNDER CURVE; BODY MASS INDEX; CORTICOTROPIN-RELEASING HORMONE; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; MALE; MATCHED-PAIR ANALYSIS; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX;

EID: 1942445189     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00104-5     Document Type: Article

References (43)

1. Arlt W., Callies F., van Vlijmen J.C., Koehler I., Reincke M., Bidlingmaier M., Huebler D., Oettel M., Ernst M., Schulte H.M., Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341:1999;1013-1020.
2. Barrett-Connor E., Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 81:1996;59-64.
3. Barrett-Connor E., von Muhlen D., Laughlin G.A., Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 47:1999;685-691.
4. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., Wallace E.P. Development of a fatigue scale. J. Psychosom. Res. 37:1993;147-153.
5. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocrine Reviews. 24:2003;236-252.
6. Cleare A.J., Blair D., Chambers S., Wessely S. Urinary free cortisol in chronic fatigue syndrome. Am. J. Psychiatry. 158:2001a;641-643.
7. Cleare A.J., Heap E., Malhi G.S., Wessely S., O'Keane V., Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 353:1999;455-458.
8. Cleare A.J., Miell J., Heap E., Sookdeo S., Young L., Malhi G.S., O'Keane V. Hypothalamo-pituitary-adrenal axis function in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J. Clin. Endocrinol. Metab. 86:2001b;3545-3554.
9. Cleare A.J., Sookdeo S., Jones J., O'Keane V., Miell J. Plasma leptin in chronic fatigue syndrome, and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion. Clin. Endocrinol. 55:2001c;113-119.
10. De Becker P., De Meirleir K., Joos E., Campine I., Van Steenberge E., Smitz J., Velkeniers B. Dehydro epiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm. Metab. Res. 31:1999;18-21.
11. Demitrack M., Dale J., Straus S., Laue L., Listwak S., Kruesi M., Chrousos G., Gold P. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73:1991;1224-1234.
12. Feldman H.A., Johannes C.B., Araujo A.B., Mohr B.A., Longcope C., McKinlay J.B. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol. 153:2001;79-89.
13. Feldman H.A., Johannes C.B., McKinlay J.B., Longcope C. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. Ann. Epidemiol. 8:1998;217-228.
14. Fukuda K., Straus S., Hickie I., Sharpe M., Dobbins J., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121:1994;953-959.
15. Gaab J., Huster D., Peisen R., Engert V., Heitz V., Schad T., Schurmeyer T.H., Ehlert U. Hypothalamus-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological and pharmacological stimulation. Psychosom. Med. 64:2002;951-962.
16. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. 1972;Oxford University Press, London.
17. Goldberg M., Lichten J. High androgen levels in chronic fatigue patients. J. Clin. Endocrinol. Metab. 80:1995;3390-3391.
18. Goodyer I.M., Park R.J., Netherton C.M., Herbert J. Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology. Br. J. Psychiatry. 179:2001;243-249.
19. Hamilos D.L., Nutter D., Gershtenson J., Redmond D.P., Clementi J.D., Schmaling K.B., Make B.J., Jones J.F. Core body temperature is normal in chronic fatigue syndrome. Biol. Psychiatry. 43:1998;293-302.
20. Himmel P., Seligman T. A pilot study employing dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J. Clin. Rheumatol. 5:1999;56-59.
21. Holsboer F. Neuroendocrinology of mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;957-969 Raven Press, New York.
22. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A., Herbert J., Chatterjee V.K. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85:2000;4650-4656.
23. Kuratsune H., Yamaguti K., Sawada M., Kodate S., Machii T., Kanakura Y., Kitani T. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int. J. Mol. Med. 1:1998;143-146.
24. McKenzie R., O'Fallon A., Dale J., Demitrack M., Sharma G., Deloria M., Garica-Borreguero D., Blackwlder W., Straus S. Low-dose hydrocortisone treatment of chronic fatigue syndrome: results of a placebo-controlled study of its efficacy and safety. J. Am. Med. Assoc. 280:1998;1061-1066.
25. Moorkens G., Berwaerts J., Wynants H., Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin. Endocrinol. 53:2000;99-106.
26. Mundt J.C., Marks I.M., Sheor M.K., Griest J.M. The work and social adjustment scale: a simple measure of impairment in functioning. Br. J. Psychiatry. 180:2002;461-464.
27. Ottenweller J.E., Sisto S.A., McCarty R.C., Natelson B.H. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology. 43:2001;34-41.
28. Parker A.J.R., Wessely S., Cleare A.J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med. 31:2001;1331-1345.
29. Scott L., Medbak S., Dinan T. The low dose ACTH test in chronic fatigue syndrome and in health. Clin. Endocrinol. 48:1998a;733-737.
30. Scott L.V., Dinan T.G. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J. Affect. Disord. 47:1998;49-54.
31. Scott L.V., Medbak S., Dinan T.G. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr. Scand. 97:1998;450-457.
32. Scott L.V., Salahuddin F., Cooney J., Svec F., Dinan T.G. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J. Affect. Disord. 54:1999;129-137.
33. Scott L.V., Svec F., Dinan T. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatry Res. 97:2000;21-28.
34. Sharpe M., Archard L., Banatvala J., Borysiewicz L., Clare A., David A., Edwards R., Hawton K., Lambert H., Lane R. Chronic fatigue syndrome: guidelines for research. J. R. Soc. Med. 84:1991;118-121.
35. Sharpe M., Chalder T., Palmer I., Wessely S. Chronic fatigue syndrome. A practical guide to assessment and management. Gen. Hosp. Psychiatry. 19:1997;185-199.
36. Stewart A., Hays R., Ware J. The MOS short-form general health survey: reliability and validity in a patient population. Med. Care. 26:1988;724-732.
37. Strickland P., Morriss R., Wearden A., Deakin W. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J. Affect. Disord. 47:1998;191-194.
38. van Niekerk J.K., Huppert F.A., Herbert J. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology. 26:2001;591-612.
39. van Rensburg S.J., Potocnik F.C., Kiss T., Hugo F., van Zijl P., Mansvelt E., Carstens M.E., Theodorou P., Hurly P.R., Emsley R.A., Taljaard J.J. Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Res. Bull. 55:2001;319-325.
40. Wessely S., Hotopf M., Sharpe M. Chronic Fatigue and its Syndromes. 1998;Oxford University Press, Oxford.
41. Wittenborn J., Buhler R. Somatic discomforts among depressed women. Arch. Gen. Psychiatry. 36:1979;465-471.
42. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry. 156:1999;646-649.
43. Young A.H., Gallagher P., Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am. J. Psychiatry. 159:2002;1237-1239.